Slaughter and May is advising Temasek - investment as part of a consortium in Alvogen
Slaughter and May is supporting the legal team at Temasek, the Singapore-based investment company, on Temasek's investment, as part of a consortium alongside CVC Capital Partners and others, in Alvogen, the generic pharmaceutical company.
CONTACTS
Corporate and Commercial: Nigel Boardman (partner), Richard Marron (associate); Tax: Steve Edge (partner), Stefan Farahani (associate).